Digital Biomarker Market
- 2026 年市場規模
- USD 4,850 Mn
- 2033 年預估規模
- USD 16,900 Mn
- 年複合成長率 CAGR
- 19.5%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Digital Biomarker Market, By Type (Diagnostic Biomarkers, Monitoring Biomarkers, and Predictive and Prognostic Biomarkers), By Data Type (Physiological Data, Behavioral Data, and Biochemical / Multi-modal Data), By Technology Platform (Wearable Devices, Mobile Applications, and Sensors and Remote Monitoring Devices), By End User (Pharmaceutical and Biotechnology Companies, Healthcare Providers, Research Organizations, and Others), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)
報告摘要
The global digital biomarker market is estimated to be valued at USD 4,850 Mn in 2026 and is expected to reach USD 16,900 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of 19.5% from 2026 to 2033. Digital biomarkers are considered to be a revolutionary development in modern healthcare since they provide an opportunity for quantitative analysis of biological data by means of various digital technologies like wearable devices, smartphones, and other types of sensors. As opposed to regular biomarkers, which require frequent visits to clinics and tests, digital biomarkers allow collecting information continuously and passively, thus allowing for a more accurate assessment of patients' health, progress of various diseases, and treatment outcomes. The evolution of digital biomarkers is contributing to the transformation of current healthcare towards data-driven and outcomes-oriented models.
The global digital biomarker industry includes various applications in therapeutic areas that include cardiovascular diseases, neurological disorders, respiratory disorders, mental health conditions, and others. Digital biomarkers can be generated from a variety of data sources, including physiological information, behavioral data, environmental indicators, and other types of information. Technological advancements in sensors, cloud computing, and data aggregation are contributing to the growth and adoption of digital biomarkers.
Market Dynamics
The global digital biomarker market has been driven by increased digitization of healthcare operations and value-driven healthcare delivery and research. More specifically, stakeholders in the healthcare field are looking for a way to gather frequent and objective data on patients to improve their decision-making capabilities and patient treatment outcomes. With the help of digital biomarkers, patients can collect data and use it as quantifiable digital endpoints that will be applied in clinical settings and pharmaceutical research. Additionally, cloud computing systems, as well as mHealth technology and improved data interoperability, increase the scalability and applicability of the aforementioned solutions.
However, the limitations of using digital biomarkers in healthcare include the inability to control the variability of data generated across different devices, insufficiently validated solutions, and difficulties connected to data governance. Nonetheless, multiple opportunities lie in the application of digital twin technology, multi-modal data analysis, and collaboration among different parties from various sectors including healthcare, pharmaceuticals, and technology. The expansion of the application range of digital biomarkers from research to population health management, risk identification, and treatment can further contribute to the growth of the market for digital biomarker.
Key Features of the Study
• This report provides in-depth analysis of the global digital biomarker market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global digital biomarker market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include AliveCor Inc., BioSensics, Evidation Health, Empatica Inc., Koneksa Health, Huma Therapeutics, Altoida AG, IXICO plc, Oura Health, and Verily Life Sciences
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global digital biomarker market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global digital biomarker market
Market Segmentation
• Type Insights (Revenue, USD Mn, 2021 - 2033)
o Diagnostic Biomarkers
o Monitoring Biomarkers
o Predictive and Prognostic Biomarkers
• Data Type Insights (Revenue, USD Mn, 2021 - 2033)
o Physiological Data
o Behavioral Data
o Biochemical / Multi-modal Data
• Technology Platform Insights (Revenue, USD Mn, 2021 - 2033)
o Wearable Devices
o Mobile Applications
o Sensors and Remote Monitoring Devices
• End User Insights (Revenue, USD Mn, 2021 - 2033)
o Pharmaceutical and Biotechnology Companies
o Healthcare Providers
o Research Organizations
o Others
• Regional Insights (Revenue, USD Mn, 2021 - 2033)
o North America
U.S.
Canada
o Latin America
Brazil
Argentina
Mexico
Rest of Latin America
o Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East
GCC Countries
Israel
Rest of Middle East
o Africa
South Africa
North Africa
Central Africa
• Key Players Insights
o AliveCor Inc.
o BioSensics
o Evidation Health
o Empatica Inc.
o Koneksa Health
o Huma Therapeutics
o Altoida AG
o IXICO plc
o Oura Health
o Verily Life Sciences
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
Market Definition and Scope
o Executive Summary
Global Digital Biomarker Market, By Type
Global Digital Biomarker Market, By Data Type
Global Digital Biomarker Market, By Technology Platform
Global Digital Biomarker Market, By End User
Global Digital Biomarker Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
o Impact Analysis
o Key Highlights
o Regulatory Scenario
o Product Launches/Approvals
o PEST Analysis
o PORTER’s Analysis
o Market Opportunities
o Regulatory Scenario
o Key Developments
o Industry Trends
4. Global Digital Biomarker Market, By Type, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Diagnostic Biomarkers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Monitoring Biomarkers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Predictive and Prognostic Biomarkers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
5. Global Digital Biomarker Market, By Data Type, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Physiological Data
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Behavioral Data
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Biochemical / Multi-modal Data
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
6. Global Digital Biomarker Market, By Technology Platform, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Wearable Devices
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Mobile Applications
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Sensors and Remote Monitoring Devices
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
7. Global Digital Biomarker Market, By End User, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Pharmaceutical and Biotechnology Companies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Healthcare Providers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Research Organizations
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
8. Global Digital Biomarker Market, By Region, 2021 - 2033, Value (USD Mn)
o Introduction
Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
Regional Trends
o North America
Introduction
Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Data Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Technology Platform, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o U.S.
o Canada
o Latin America
Introduction
Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Data Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Technology Platform, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o Brazil
o Argentina
o Mexico
o Rest of Latin America
o Europe
Introduction
Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Data Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Technology Platform, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o Germany
o U.K.
o Spain
o France
o Italy
o Russia
o Rest of Europe
o Asia Pacific
Introduction
Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Data Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Technology Platform, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o China
o India
o Japan
o Australia
o South Korea
o ASEAN
o Rest of Asia Pacific
o Middle East
Introduction
Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Data Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Technology Platform, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o GCC Countries
o Israel
o Rest of Middle East
o Africa
Introduction
Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Data Type, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Technology Platform, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
o South Africa
o North Africa
o Central Africa
9. Competitive Landscape
o AliveCor Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o BioSensics
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Evidation Health
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Empatica Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Koneksa Health
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Huma Therapeutics
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Altoida AG
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o IXICO plc
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Oura Health
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Verily Life Sciences
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
10. Analyst Recommendations
o Wheel of Fortune
o Analyst View
o Coherent Opportunity Map
11. References and Research Methodology
o References
o Research Methodology
o About us
*Browse 32 market data tables and 28 figures on 'Digital Biomarker Market' - Global forecast to 2033
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們